FindMyKOL

Mackenzie Cervenka, MD

Enriched profile

Professor of Neurology · Johns Hopkins Hospital

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyNeurologyFocusEpilepsy research and treatment+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2024–2025NIH fundingNone on fileWhy? →

Mackenzie Cervenka is Professor of Neurology at Johns Hopkins Hospital. OpenAlex indexes 111 publications with 3,636 citations (h-index 36); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 4 Nov 2026

Overview

Updated 4 Nov 2026

Mackenzie Cervenka, MD, is Professor of Neurology at Johns Hopkins Hospital, School of Medicine. The public record shows 111 publications with 3,636 citations (h-index 36), centered on Epilepsy research and treatment, Diet and metabolism studies, Dietary Effects on Health. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 3 companies.

  • Most recent indexed publication: 2026 · Nutrients
  • Top research focus: Epilepsy research and treatment
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 4 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Epilepsy4 trialsSeizures4 trialsDyslipidemia / Lipid Disorders1 trialStroke1 trialCoronary Artery Disease / ACS1 trialCarotid Intimal Medial Thickness 11 trialStatus Epilepticus1 trialCOVID-191 trialType 2 DiabetesCIDP / Inflammatory NeuropathySubstance Use DisordersNeuro-Oncology / GliomaAlzheimer's / DementiaMigraine / Headache

Research focus

OpenAlex concept fingerprint
Epilepsy research and treatmentDiet and metabolism studiesDietary Effects on HealthEEG and Brain-Computer InterfacesMetabolism and Genetic Disorders

Drugs & molecules

across trials, industry payments and publications
FYCOMPAgeneric · PerampanelClinical trials—Industry payments1Publications—Xcoprigeneric · CenobamateClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Johns Hopkins UniversityClinical trials5Industry payments—SK Life Science, Inc.Clinical trials—Industry payments2Catalyst Pharmaceuticals, Inc.Clinical trials—Industry payments1LivaNova USA, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
111publications

Publications indexed by OpenAlex, matched via ORCID. 17 in PubMed. Counts exclude supporting files.

3,636citations

Citations across these publications.

36h-index

H-index from these publications. i10-index 59.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2024–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Medical director

    Johns Hopkins Adult Epilepsy Diet Center

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 4 Nov 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

All 5 trial records: search, sort and filter.Explore →

Industry payments

Updated 4 Nov 2026

3 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:

All 4 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    97.8%
    Other antiepileptics55%
    Lacosamide37%Xcopri28%Briviact14%Levetiracetam9%Epidiolex8%Topiramate5%
    Part D<11 patients
    Benzodiazepine21.1%
    Clobazam64%Lorazepam27%Nayzilam10%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.2%
    Metabolic Alkalinizer2.2%
    Potassium Citrate Er100%
    Part D<11 patients
Where care is delivered (Part B)85.9% facility · 14.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 4 Nov 2026

3 congress contributions (2019–2026) across AAN, SNO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 4 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 17 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
All 111 cited works: search, sort and filter.Explore →

Online presence

Updated 4 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/mackenzie-cervenka-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Mackenzie-Cervenka

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    profiles.hopkinsmedicine.org/provider/mackenzie-cervenka/2708209

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Other

    pure.johnshopkins.edu/en/persons/mackenzie-cervenka

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pure.johnshopkins.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 4 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chair

    Task Force on Ketogenic Diet Therapies

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ilae.org ↗
  • Member

    Dietary Treatments Task Force

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ilae.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.